Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 6, No 4 (2010) CLOPIDOGREL PHARMACOGENETICS Abstract  similar documents
A. N. Meshkov
"... of clopidogrel play an important role in the resistance development. Allel variants of the gene cytochrome CYP2C ..."
 
Vol 14, No 1 (2018) NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev
"... of carriership of at least one CYP4F2*3 allele on the risk of resistance to clopidogrel in patients with acute ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
"... .1 in the CYP2C19*1/*1 group vs 18.2±16.4 in the CYP2C19*1/*2 one (р=0.03). Clopidogrel laboratory resistance (P ..."
 
Vol 11, No 1 (2015) EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Andreev, D. A. Sychev
"... of clopidogrel, the association of residual platelet reactivity with clinical outcomes and a review ..."
 
Vol 9, No 4 (2013) THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev
"... The clinical significance  of CYP2C19 genetic polymorphism, associated with the violation ..."
 
Vol 13, No 6 (2017) CYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE Abstract  similar documents
A. I. Akhmetova, E. B. Kleimenova, D. A. Sychev, O. V. Parshina, L. P. Yashina
"... Aim. To study the use of CYP2C19 pharmacogenetic testing (PhGT) for personalization ..."
 
Vol 6, No 2 (2010) THE MODERN ASPECTS OF CLOPIDOGREL USE Abstract  similar documents
E. N. Dankovtseva, D. A. Zateyshchikov
"... The possibilities and evidence base of clopidogrel use in clinical practice are discussed. Data ..."
 
Vol 8, No 1 (2012) RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
V. A. Sulimov, E. V. Moroz
"... Aim. To study prevalence of resistance to acetylsalicylic acid, clopidogrel and dual resistance ..."
 
Vol 6, No 4 (2010) ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY? Abstract  similar documents
S. J. Martsevich
"... The ACC/AHA clopidogrel clinical alert about the possibility of ineffective treatment ..."
 
Vol 14, No 5 (2018) Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case Abstract  similar documents
M. A. Andreyanova, K. B. Mirzaev, D. A. Sychev, K. A. Ryzhikova, A. V. Pokrovsky, A. F. Kharazov
"...   for resistance to antiplatelet therapy with clopidogrel. The decrease in the effectiveness of prolonged therapy ..."
 
Vol 10, No 6 (2014) СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY? Abstract  similar documents
S. Yu. Martsevich, A. Yu. Suvorov
"... Concomitant administration of clopidogrel and proton pump inhibitors (PPI), the possible influence ..."
 
Vol 3, No 3 (2007) RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
"... ингиби- торами цитохрома P450(CYP)3A4, подавляют антиагре- гантные свойства клопидогреля. Напротив ..."
 
Vol 7, No 6 (2011) ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS Abstract  similar documents
L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo
"... Aim. To analyze the literary and own data about clopidogrel influence on platelets during ..."
 
Vol 13, No 5 (2017) INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION Abstract  similar documents
E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash
"... Aim. To study the effect of replacing clopidogrel with ticagrelor on endpoints of hospital period ..."
 
Vol 13, No 1 (2017) MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
N. F. Puchinian, N. V. Furman, L. I. Malinova, P. V. Dolotovskaya
"... % 100 80 60 40 20 0 No CA / Без КАГ After CA / После КАГ ASA АСК Clopidogrel Клопидогрел ..."
 
Vol 7, No 1 (2011) THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS Abstract  similar documents
O. V. Gaisenok
"... in patients with cardioascular diseases are discussed. Role of clopidogrel in contemporary antiplatelet ..."
 
Vol 7, No 1 (2011) THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY Abstract  similar documents
V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev
"... Aim. To study therapeutic equivalence (efficacy, safety and tolerability) of original clopidogrel ..."
 
Vol 12, No 5 (2016) Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention Abstract  similar documents
E. Z. Golukhova, M. V. Grigoryan, M. N. Ryabinina, N. I. Bulaeva
"... antiplatelet therapy with acetyl salicylic acid and clopidogrel. Numerous clinical characteristics ..."
 
Vol 8, No 2 (2012) RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS Abstract  similar documents
A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova
"... Aim. To compare effects of acetylsalicylic acid (ASA) and two clopidogrel drugs on residual ..."
 
Vol 7, No 3 (2011) MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya, T. G. Kheliya, N. P. Kutishenko
"... Aim. To study a rate of clopidogrel use in patients having indications for clopidogrel therapy ..."
 
Vol 12, No 4 (2016) High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice Abstract  similar documents
N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova
"... antiplatelet therapy (DAT) with acetylsalicylic acid (ASA) and clopidogrel by optical aggregometry in patients ..."
 
Vol 5, No 5 (2009) EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi
"... and morphology of erythrocytes and to assess their changes during therapy with acetylsalicylic acid, emclopidogrel/em ..."
 
Vol 3, No 2 (2007) VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY Abstract  similar documents
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes
"... of polymorphisms of genes of their biotransformation (emCYP/em2C9) and molecule-targets (VKORC1). This created basis ..."
 
Vol 8, No 2 (2012) UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev
"... Aim. To assess the real rate of dual antiplatelet therapy (DAT, acetylsalicylic acid + emclopidogrel/em ..."
 
Vol 7, No 5 (2011) HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY  similar documents
G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio
"... Введение. Полученные ранее данные свидетельствуют о наличии у emклопидогрела/em не только ..."
 
Vol 9, No 1 (2013) POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova
"... and induced flow cytofluorometry during antiplatelet therapy with emclopidogrel/em and acetylsalicylic acid (ASA ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... , warfarin, ticlopidine and emclopidogrel/em are discussed. Study data on new antiplatelet drugs are given ..."
 
Vol 11, No 4 (2015) EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. V. Rudakova, N. V. Lomakin
"... Dual antiplatelet therapy, including emclopidogrel/em and aspirin, in a significant share of patients ..."
 
Vol 14, No 6 (2018) P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva
"... with emclopidogrel/em or ticagrelor was performed, as well as of all 3 P2Y12-receptor inhibitors among themselves ..."
 
Vol 10, No 6 (2014) PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING Abstract  similar documents
N. V. Shcherbakova, A. I. Ershova, A. A. Suvorova, E. Y. Hlebus, A. N. Meshkov, S. A. Boytsov
"... результатам экзомного секвенирования участника нашего исследования emаллельных/em вариантов, требующих коррекции ..."
 
Vol 4, No 2 (2008) ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION Abstract  similar documents
D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov
"... Aim. To evaluate the incidence of acetylsalicylic acid (ASA) and emclopidogrel/em resistance ..."
 
Vol 14, No 2 (2018) WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
M. Yu. Gilyarov, Е. V. Konstantinova
"... of reperfusion and the selected treatment strategy. Due to some limitations in the use of emclopidogrel/em ..."
 
Vol 5, No 3 (2009) ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva
"... Aim. To study a rate of resistance to acetylsalicylic acid (ASA) and emclopidogrel/em and clinical ..."
 
Vol 9, No 5 (2013) APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA Abstract  similar documents
D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev
"... Фармакогенетическое тестирование при использовании пероральных антикоагулянтов • emCYP/em2C9 (носительство emаллельных/em ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... , 62.1% of men) were included into the study. Polymorphism Phe189Ser of the emCYP/em3A4 (gene encoding ..."
 
Vol 9, No 6 (2013) THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY Abstract  similar documents
A. V. Shulkin, E. N. Yakusheva, N. M. Popova
"... ), encoding P-glycoprotein, in pharmacotherapy with digoxin, antiplatelet drugs (emclopidogrel/em tikagrelol ..."
 
Vol 10, No 5 (2014) DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE Abstract  similar documents
G. N. Guseva, T. V. Pavlova, I. L. Voronova, S. M. Chohlunov
"... .8% of patients also received combination of emclopidogrel/em and acetylsalicylic acid, but changed medicinal products ..."
 
Vol 9, No 3 (2013) ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT Abstract  similar documents
E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts
"... эффектов [30]. Наибольшее число исследований посвящено влиянию носительства 2 emаллельных/em вариантов гена emCYP/em2 ..."
 
Vol 14, No 4 (2018) Role of Single Nucleotide Polymorphism of СУР17А Gene in the Development of Stroke Abstract  similar documents
S. Yu. Nikulina, V. A. Shulman, A. A. Chernova, D. A. Nikulin, A. A. Semenchukov, O. V. Marilovceva, S. S. Tret'jakova, I. I. Lebedeva, V. N. Maksimov
"...  emCYP/em17A1 is one of the many genes that can participate in the formation of predisposition ..."
 
Vol 10, No 6 (2014) THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY Abstract  similar documents
D. A. Andreev
"... с ВОРТ (emPRU/em 208) были рандомизированы в группы прасугрела 10 мг/сут или emклопидогрела/em 75 мг/сут ..."
 
Vol 7, No 4 (2011) VASCULAR BED PECULIAR PROPERTIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION. ROLE OF ANTIPLATELET THERAPY Abstract  similar documents
L. A. Haisheva, S. V. Shlyk
"... of revealed disorders with antiplatelet agent — emclopidogrel/em 75 mg/day. Material and methods. 40 patients ..."
 
Vol 7, No 1 (2011) NEW ANTIPLATELET DRUGS (PART 1) Abstract  similar documents
A. B. Sumarokov
"... emклопидогрела/em снижена. Наиболее частые генетические варианты полимор- физма emCYP/em 2В6, emCYP/em 2С9, emCYP/em2С19, emCYP/em 3A5 ..."
 
Vol 11, No 2 (2015) CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE Abstract  similar documents
K. A. Kireev, A. V. Krasnopeev, T. S. Kireeva
"... antiplatelet drugs (acetylsalicylic acid and emclopidogrel/em) and heparin. There were not any reasons ..."
 
Vol 11, No 5 (2015) Subscription to the journal Abstract  similar documents
article Editorial
"... ) ISSN 1819-6446 (Print) ISSN 2225-3653 (Online) emCYP/em3A4 and emCYP/em2C19: emclopidogrel/em antiplatelet effect in ..."
 
Vol 15, No 3 (2019) Multi-Ethnic Analysis of Cardiac Pharmacogenetic Markers of Cytochrome P450 and Membrane Transporters Genes in the Russian Population Abstract  similar documents
K. B. Mirzaev, D. S. Fedorinov, D. V. Ivashchenko, D. A. Sychev
"... ", "cardiology" together with the terms associated with the polymorphic marker, including: «P450», «emCYP/em2C19 ..."
 
Vol 12, No 5 (2016) Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms Abstract  PDF (Eng)  similar documents
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev
"... Aim. To evaluate treatment adherence and prevalence of emCYP/em2C9 and VKORC1 gene mutations ..."
 
Vol 14, No 1 (2018) NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Ju. P. Skirdenko, N. A. Nikolayev
"... , polymorphism of genes emCYP/em2C9 and VKORC1 and the structure of food preferences. Results. Persons ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... + emclopidogrel/em) can be prescribed to elderly patients with cardiovascular comorbidity who are deemed unsuitable ..."
 
Vol 8, No 4 (2012) ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina, A. G. Larin
"... круга больных с ишемической болезнью сердца (ИБС) при добавлении emклопидогрела/em к аспирину [10, 11]. В ..."
 
Vol 15, No 2 (2019) The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention Abstract  similar documents
A. S. Tereshchenko, E. V. Merkulov, A. N. Samko, S. A. Abugov
"... is emclopidogrel/em. It has been proven that the use of emclopidogrel/em to date not always reduces the risk of development ..."
 
Vol 13, No 3 (2017) PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION Abstract  similar documents
A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko
"... кровотечения при приеме ривароксабана у пациента-носителя emаллельных/em вариантов по полиморфизмам rs2032582 и rs ..."
 
Vol 7, No 6 (2011) CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM Abstract  similar documents
Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov
"... therapy (acetylsalicylic acid, emclopidogrel/em, warfarin) was made on the 4th day of disease onset taking ..."
 
Vol 7, No 6 (2011) PHARMACOTHERAPY ANALYSIS OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN HOSPITALS OF VARIOUS TYPES Abstract  similar documents
R. M. Magdeev, O. V. Reshetko, E. Y. Rudnichenko, N. V. Furman, P. V. Dolotovskaya, T. Y. Grozdova, L. N. Volkova
"... , and emclopidogrel/em was not prescribed. At the same hospital clotting time was determined for monitoring of heparin ..."
 
Vol 9, No 6 (2013) ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS? Abstract  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein
"... (множе- ственное поражение сосудов) и генетические (emCYP/em2C19*2/*3) [7,8,11]. Недавние исследования ..."
 
Vol 11, No 5 (2015) Practical aspects of apixaban use in clinical practice: continuing the theme Abstract  similar documents
S. N. Bel'diev
"... Currently there are no generally accepted guidelines for the use of apixaban together with emCYP/em3A4 ..."
 
Vol 7, No 5 (2011) NEW ANTIPLATELET DRUGS. PART 2 Abstract  similar documents
A. B. Sumarokov
"... повышенных её значениях — относительно неудобное свойство emклопидогрела/em. В настоящее время для более быстрого ..."
 
Vol 12, No 5 (2016) Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome Abstract  similar documents
I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova
"... with ASA and emclopidogrel/em, risk of thrombotic events is saved in ASA resistant patients with ACS ..."
 
Vol 14, No 2 (2018) DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT Abstract  similar documents
N. В. Perepech, A. V. Tregubov
"... . 51.8% of respondents recommend a combination of acetylsalicylic acid and emclopidogrel/em ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... in trials and proven efficacy in the prevention of stroke/systemic embolism, the use of emclopidogrel/em ..."
 
Vol 14, No 6 (2018) Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation Abstract  PDF (Eng)  similar documents
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee
"... pharmacies. Among antiplatelet agents, aspirin was available in most pharmacies, and emclopidogrel/em was mostly ..."
 
Vol 14, No 6 (2018) Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice Abstract  PDF (Eng)  similar documents
K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova
"... (3.8%) patients. Aspirin was the only antiplatelet agent in 3 cases and emclopidogrel/em – in one case ..."
 
Vol 9, No 6 (2013) THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) Abstract  similar documents
V. A. Sulimov
"... by half in patients aged ≥75 years) in combination with emclopidogrel/em and enoxaparin followed by admission ..."
 
Vol 14, No 1 (2018) COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman
"... receptors (AMCR), diuretics, oral anticoagulants, emclopidogrel/em increased (p0.05). In the structure ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... with emclopidogrel/em (up to 5.4%) was registered at the second stage of the study. Over a five-year period bisoprolol ..."
 
Vol 9, No 1 (2013) OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS Abstract  PDF (Eng)  similar documents
S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap
"... : antiplatelet agents – in 60.4% of the cases (584 patients received acetylsalicylic acid and 20 – emclopidogrel/em ..."
 
Vol 5, No 3 (2009) SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS Abstract  similar documents
E. S. Kropacheva
"... emаллельных/em вариантов двух ос- новных ферментов биотрансформации АВК — emCYP/em2C9 и VKORC1? Возобновление ..."
 
Vol 5, No 5 (2009) ANTIAGGREGANT THERAPY OVERCOMES LIMITS Abstract  similar documents
I. Andreeva
"... На отечественном фармацевтическом рынке по- явился новый европейский emклопидогрел/em — Эгитромб (Эгис ..."
 
Vol 9, No 3 (2013) INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina
"... emаллельному/em варианту SLCO1B1*5. Оценивали связь между принимаемым лекарством и нежелательной реакцией с ..."
 
Vol 15, No 3 (2019) Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery Abstract  similar documents
A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein
"... +emclopidogrel/em (75 mg/day). The aggregation study was performed with an optical aggregometer, using 5 μM ..."
 
Vol 8, No 2 (2012): РЕКОМЕНДАЦИИ ПО ЛЕЧЕНИЮ ОСТРОГО КОРОНАРНОГО СИНДРОМА БЕЗ СТОЙКОГО ПОДЪЕМА СЕГМЕНТА ST Abstract  similar documents
, , , , , , , , , , , , , , , ,
"... , бивалирудин, шунтирование, отделение неотложной кардиологии, emклопидогрел/em, диабет, эноксапарин, Европейское ..."
 
Vol 4, No 2 (2008) EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY Abstract  similar documents
A. V. Semenov, D. A. Sichev, V. G. Kukes
"... . Существование различных emаллельных/em вариантов одного и того же гена в популя- ции носит название генетического ..."
 
Vol 11, No 2 (2015) PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST Abstract  similar documents
D. A. Sychev, I. I. Sinitsina, G. Yu. Zakharova, M. I. Savel'eva, A. V. Ryabova, A. V. Kryukov, A. Yu. Yurovskii
"... laboratory control and monitoring are needed, drugs interactions (at the level of emCYP/em3A4, P-gp), management ..."
 
Vol 4, No 3 (2008) ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS Abstract  similar documents
V. A. Sulimov
"... (Тиклид) b. emКлопидогрель/em (Плавикс) 3. Блокаторы IIb/IIIa гликопротеино- вых рецепторов тромбоцитов a ..."
 
Vol 7, No 1 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... по своей эффективности (на 40%) соче- тание emклопидогрела/em и АСК по данным исследования ACTIVE-W [7 ..."
 
Vol 6, No 1 (2010) ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... полиморфизмов гена цитохрома emCYP/em2C9 и гена фермента витамин-К-эпоксид редуктазы. По дан- ным различных авторов ..."
 
Vol 12, No 1 (2016) Acute coronary syndrome and renal dysfunction Abstract  similar documents
F. I. Belyalov
"... /мин/1,73 м2) 1 (≥90) 2 (60-89) 3 (30-59) 4 (15-29) 5 (15) Аспирин + + + + + emКлопидогрел/em ..."
 
Vol 12, No 3 (2016) THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE Abstract  PDF (Eng)  similar documents
A. V. Kryukov, D. A. Sychev, D. A. Andreev, A. V. Ryabova, N. P. Denisenko, M. A. Loskutnikov, O. I. Vinogradov, M. A. Domashenko
"... ; age ≥90 years; concomitant use of drugs – inhibitors of emCYP/em3A4 and P-glycoprotein (ketoconazole ..."
 
Vol 8, No 3 (2012) RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
M. Yu. Gilyarov
"... сочетание emклопидогрела/em и АСК по данным ис- следования ACTIVE-W [6]. Хотя терапия варфарином ..."
 
Vol 13, No 1 (2017) FROM PERSONALIZED TO PRECISION MEDICINE Abstract  similar documents
K. V. Raskina, E. Y. Martynova, A. V. Perfilyev, D. A. Sychev, G. N. Shuev, I. R. Fatkhutdinov, S. V. Musienko, D. A. Nikogosov, I. O. Zhegulina, L. G. Bavykina, Y. E. Poteshkin
"... , соответственно. emКлопидогрел/em менее эффективен для лиц, несущих аллели emCYP/em2C19*2 или emCYP/em2C19*3, и их «обладателями ..."
 
Vol 11, No 1 (2015) ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE Abstract  similar documents
M. V. Solodun, S. S. Yakushin
"... ТС уменьшение атерогенных фракций холестерина было статистически значимым (p0,05). emАллельный/em ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov
"... ), с чем связано ее частое при- менение у лиц с данными нозологическими формами [2-4]. emКлопидогрел/em в ..."
 
Vol 7, No 3 (2011) STROKE PREVENTION IN INTERNIST PRACTICE Abstract  similar documents
D. A. Napalkov, A. V. Zhilenko
"... группы: АСК+дипиридамол за- медленного высвобождения и emклопидогрел/em (средняя продолжительность наблюдения ..."
 
Vol 7, No 5 (2011) HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko
"... (ACC/AHA/SCAI, 2005) acting at the time. After PCI patients were prescribed aspirin, emclopidogrel/em ..."
 
Vol 10, No 6 (2014) THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER Abstract  similar documents
S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina
"... ;(6):24–31. Russian (Сироткина О.В., Улитина А.С., Тараскина А.Е. и др. emАллельные/em варианты emCYP/em2C9*2 и ..."
 
Vol 9, No 6 (2013) APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY Abstract  similar documents
D. A. Sychev, G. N. Shuev, A. B. Prokofiev
"... гетерозиготного (генотип с.521ТС) или гомозиготного (генотип с.521СС) носи- тельства emаллельного/em варианта SLCO1B1*5 ..."
 
Vol 8, No 2 (2012): КОММЕНТАРИИ К НОВОМУ ВАРИАНТУ ЕВРОПЕЙСКИХ КЛИНИЧЕСКИХ РЕКОМЕНДАЦИЙ ПО ТАКТИКЕ ЛЕЧЕНИЯ БОЛЬНЫХ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ БЕЗ СТОЙКОГО ПОДЪЕМА СЕГМЕНТА ST Abstract  similar documents
"... первого ряда, в то вре- мя как прием emклопидогрела/em считается допустимым только у больных, которые по той ..."
 
Vol 7, No 4 (2011) PROTHROMBOTIC POLYMORPHISMS AND LONG-TERM PROGNOSIS OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE Abstract  similar documents
A. L. Komarov, O. O. Shahmatova, D. V. Rebrikov, D. Yu. Trophimov, T. I. Kotkina, T. A. Ilyushenko, A. D. Deev, E. P. Panchenko
"... уровня общего билирубина). Все больные были генотипированы по emаллельным/em ва- риантам генов, кодирующих ..."
 
Vol 5, No 6 (2009) RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID Abstract  similar documents
N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky
"... ацетилсалициловая кислота (АСК) и emклопидогрел/em [4]. АСК, emклопидогрел/em или их сочетание («двойная ан- титромбоцитарная ..."
 
Vol 7, No 3 (2011) THE NEWS FROM RECENT CONGRESS OF AMERICAN COLLEGE OF CARDIOLOGY (NEW ORLEANS, APRIL 2-5, 2011)  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Y. Drozdova
"... покрытием можно ограничить срок прие- ма emклопидогрела/em в составе двойной антиагрегантной те- рапии (ДАТ ..."
 
Vol 10, No 4 (2014) DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... , 20%) than those with combination of AF and IHD (19 of 515; 3.7%), p=0.002. Aspirin and emclopidogrel/em ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
"... сравнение варфарина и ком- бинации аспирина и emклопидогрела/em — исследование ACTIVE-W (2006), включившее 6 706 ..."
 
Vol 9, No 3 (2013) TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN Abstract  similar documents
A. I. Martynov, E. V. Akatova, I. V. Urlayeva, O. P. Nicolin
"... ингибитор тромбоцитов (emклопидогрел/em). В исследова- ние были включены здоровые некурящие доброволь- цы в ..."
 
Vol 6, No 4 (2010) ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS Abstract  similar documents
A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov
"... emклопидогрела/em. В ис- следовании ACTIVE оценивались эффективность и безопасность сочетания аспирина и ..."
 
Vol 9, No 6 (2013) DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. D. Deev, S. A. Boytsov
"... treatment of IHD / Динамика лекарственной терапии при ИБС acetylsalicylic acid (ASA) and emclopidogrel/em (level ..."
 
Vol 5, No 4 (2009) GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY Abstract  similar documents
A. L. Komarov
"... при- менять emклопидогрель/em или тиклопидин, как препараты с менее выраженными ульцерогенными свойствами ..."
 
Vol 10, No 2 (2014) ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Maslakov
"... или в комбинации с emклопидогрелом/em в си- туациях, когда терапия антикоагулянтами противопо- казана. Из ..."
 
Vol 8, No 5 (2012) ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? Abstract  similar documents
S. A. Boldueva, I. A. Leonova
"... . Замена АСК на emклопидогрел/em не считается опти- мальной стратегией профилактики кровотечений у пациентов с ..."
 
Vol 12, No 5 (2016) Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... с участием изоферментов Р450 (emCYP/em1A2, 2C9, 2D6, 3A4 и др.), что обусловливает высокий риск ..."
 
Vol 8, No 1 (2012) RANOLAZINE IN ISCHEMIC HEART DISEASE Abstract  similar documents
V. P. Lupanov
"... ) применяют- ся антитромбоцитарные (аспирин, emклопидогрел/em), липид-снижающие препараты (статины), ингибиторы ..."
 
Vol 8, No 6 (2012) HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
S. V. Moiseev
"... - тилсалициловую кислоту (АСК) [2] и комбинированную терапию АСК и emклопидогрелом/em [3]. Недостатки варфарина ..."
 
1 - 100 of 227 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)